Cargando…
Viral burden, inflammatory milieu and CD8(+) T‐cell responses to influenza virus in a second‐generation thiazolide (RM‐5061) and oseltamivir combination therapy study
BACKGROUND: Influenza viruses cause significant morbidity and mortality, especially in young children, elderly, pregnant women and individuals with co‐morbidities. Patients with severe influenza disease are typically treated with one neuraminidase inhibitor, oseltamivir or zanamivir. These antiviral...
Autores principales: | Nüssing, Simone, Mifsud, Edin, Hensen, Luca, Koutsakos, Marios, Wang, Zhongfang, Kedzierski, Lukasz, Mercuri, Francesca, Rossignol, Jean‐Francois, Hurt, Aeron C., Kedzierska, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578329/ https://www.ncbi.nlm.nih.gov/pubmed/32588557 http://dx.doi.org/10.1111/irv.12776 |
Ejemplares similares
-
Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
por: Allen, Robert J., et al.
Publicado: (2017) -
Thiazolide
Prodrug Esters and Derived Peptides: Synthesis
and Activity
por: Stachulski, Andrew V., et al.
Publicado: (2023) -
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016) -
Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication
por: Trabattoni, Daria, et al.
Publicado: (2016) -
Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugs
por: Stachulski, Andrew V., et al.
Publicado: (2017)